<DOC>
	<DOCNO>NCT00907127</DOCNO>
	<brief_summary>The study test whether damage heart nerve appear patient develop diabetes .</brief_summary>
	<brief_title>Cardiac Autonomic Neuropathy Patients With Metabolic Syndrome</brief_title>
	<detailed_description>Patients mild abnormality blood sugar , high blood pressure , abnormal lipid and/or obesity condition call metabolic syndrome . These patient high risk diabetes Cardiac Autonomic Neuropathy ( CAN ) . Subjects diagnose metabolic syndrome expect participate Metabolic Fitness Program University Michigan diet exercise program locate Cardiology department Domino Farms Ann Arbor . Time require program study 6 month . Clinic visit involve Cardiac autonomic testing ( CAN ) procedure , PET scan labs measure pre post program intervention .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>1 . Subjects must IGT IFG two criterion metabolic syndrome define ATP III ( IFG=fasting glucose ≥ 100 mg/dl ( 5.5 mmol/l ) ) 2 . Definition IGT/IFG : IGT/IFG define base ADA diagnostic guideline follow oral glucose tolerance test ( OGTT ) [ 2 ] . 3 . Other Required Criteria ( 2 follow ) : Waist circumference ≥ 102 cm ( 40 inch ) men ≥ 88 cm ( 35 inch ) woman , { AsianAmericans : men ≥ 88 cm ( 35 inch ) , woman ≥ 78 cm ( 31 inch ) } Triglycerides ≥ 150 mg/dl ( 1.7 mmol/l ) patient drug treatment fibrates nicotinic acid presume triglyceride ≥ 150mg/dl low HDL HDL cholesterol &lt; 40 mg/dl ( 1.0 mmol/l ) men &lt; 50 mg/dl ( 1.3 mmol/l ) woman , Blood pressure ≥ 130/≥ 85 mmHg 4 . Age 1865 5 . Women childbearing potential must use contraception prevent pregnancy 1 . Patients either pregnant planning become pregnant excluded Women childbearing potential urine pregnancy test part screen visit Subjects become pregnant study undergo exit visit management IGT Metabolic Syndrome return primary care provider 2 . Subjects preexist cardiovascular disease include : myocardial infarction congestive heart failure know arrhythmias ventricular structural abnormality valvular disease peripheral vascular disease 3 . Subjects hypoxemic lung heart disease 4 . Subjects establish diabetes 5 . Laboratory evidence disease know cause neuropathy within 3 month screen exclusion ( without know abnormality remote abnormality ( &gt; 3 month ) undergo serologic screening ) 6 . Significant neurological disease ( e.g. , Parkinson 's disease , epilepsy , recent stroke ) 7 . Subjects take drug interfere uptake metabolism catecholamine 8 . Subjects know history chronic kidney disease significant hepatic disease ( AST , ALT &gt; 3 time upper limit normal ) history previous kidney , pancreas cardiac transplantation . 9 . Subjects take systemic investigational drug within last 6 month 10 . Inability unwillingness subject legal guardian/representative give write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Metabolic</keyword>
	<keyword>Syndrome</keyword>
	<keyword>CAN</keyword>
</DOC>